The reduction test Another diagnostic approach: reduce copper peptide application to every third day for one week
HSDD is estimated to affect about 10% of women in the United States, according to a 2022 review in CNS Spectrums , and Vyleesi is one of only two FDA-approved therapies specifically indicated for female sexual desire
Athletes and active individuals may find it particularly valuable for shortening downtime, protecting against overuse, and maintaining peak performance
Today, we also offer treatments for hyperhidrosis, hay fever, B12 replacement and migraines alongside weight loss management clinics, on-the-day minor illness clinics, short-wave diathermy for the safe removal of unwanted moles, lesions and thread veins, and microsclerotherapy for leg veins